IRF9 anticorps (full length)
Aperçu rapide pour IRF9 anticorps (full length) (ABIN7878452)
Antigène
Voir toutes IRF9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
Clone
-
-
Épitope
- full length
-
Fonction
- IRF9 Antibody / Interferon regulatory factor 9 (azide and preservative free)
-
Purification
- Protein A/G affinity
-
Immunogène
- Recombinant full-length human IRF9 protein was used as the immunogen for the IRF9 antibody.
-
Isotype
- IgG2a
-
-
-
-
Indications d'application
- Optimal dilution of the IRF9 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the IRF9 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
-
Autre désignation
- IRF9
-
Sujet
- Transcription regulatory factor that mediates signaling by type I IFNs (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize, associate with IRF9/ISGF3G to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state.
-
UniProt
- Q00978
-
Pathways
- Signalistation JAK/STAT, Interferon-gamma Pathway, Hepatitis C
Antigène
-